Wells-Fargo--Companymn

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
17,007
Total Value
380513686713
Accession Number
0000072971-25-000149
Form Type
13F-HR
Manager Name
Wells-Fargo--Companymn
Data Enrichment
77% identified
13,029 identified3,978 unidentified

Holdings

17,007 positions • $380.5B total value
Manager:
Search and click to pin securities to the top
Page 259 of 329
Jasper Therapeutics, Inc.
Shares:6.1K
Value:$26.3K
% of Portfolio:0.0% ($26.3K/$380.5B)
Electromed, Inc.
Shares:1.1K
Value:$26.2K
% of Portfolio:0.0% ($26.2K/$380.5B)
Purple Innovation, Inc.
Shares:34.5K
Value:$26.2K
% of Portfolio:0.0% ($26.2K/$380.5B)
RAPT Therapeutics, Inc.
Shares:21.4K
Value:$26.1K
% of Portfolio:0.0% ($26.1K/$380.5B)
KOREA FUND INC
Shares:1.3K
Value:$26.0K
% of Portfolio:0.0% ($26.0K/$380.5B)
COMPUGEN LTD
Shares:17.4K
Value:$25.9K
% of Portfolio:0.0% ($25.9K/$380.5B)
VALHI INC /DE/
Shares:1.6K
Value:$25.7K
% of Portfolio:0.0% ($25.7K/$380.5B)
45783Y855
Shares:818
Value:$25.7K
% of Portfolio:0.0% ($25.7K/$380.5B)
Tenaya Therapeutics, Inc.
Shares:44.9K
Value:$25.6K
% of Portfolio:0.0% ($25.6K/$380.5B)
45782C714
Shares:1.0K
Value:$25.5K
% of Portfolio:0.0% ($25.5K/$380.5B)
74347B557
Shares:280
Value:$25.5K
% of Portfolio:0.0% ($25.5K/$380.5B)
26922B642
Shares:1.1K
Value:$25.5K
% of Portfolio:0.0% ($25.5K/$380.5B)
Nautilus Biotechnology, Inc.
Shares:29.5K
Value:$25.4K
% of Portfolio:0.0% ($25.4K/$380.5B)
G7500M104
Shares:4.3K
Value:$25.3K
% of Portfolio:0.0% ($25.3K/$380.5B)
Roadzen Inc.
Shares:24.2K
Value:$25.2K
% of Portfolio:0.0% ($25.2K/$380.5B)
Applied Therapeutics, Inc.
Shares:51.5K
Value:$25.2K
% of Portfolio:0.0% ($25.2K/$380.5B)
LiveOne, Inc.
Shares:35.9K
Value:$25.1K
% of Portfolio:0.0% ($25.1K/$380.5B)
KULR Technology Group, Inc.
Shares:19.0K
Value:$25.1K
% of Portfolio:0.0% ($25.1K/$380.5B)
Ispire Technology Inc.
Shares:9.2K
Value:$25.1K
% of Portfolio:0.0% ($25.1K/$380.5B)
477839AB0
Shares:—
Value:$25.0K
% of Portfolio:0.0% ($25.0K/$380.5B)